UNSPSC 85604131: Bypass jejunum to transverse colon with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass jejunum to transverse colon with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0D1A47L

UNSPSC 85604131 Bypass jejunum to transverse colon with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that shows little relevant recent state and local procurement activity. The code describes a specific surgical procedure within gastrointestinal medicine, yet the recent opportunities tagged under it span occupational medical surveillance, pharmacy benefit management, temporary health professional staffing, disability medical evaluations, and surgical benefit carve-out programs—none of which involve the bariatric or reconstructive bowel procedures the code nominally covers. The mismatch suggests this code has been applied inconsistently or erroneously to health care services procurement rather than to the clinical procedure it names.

The six recent opportunities posted between July and September 2026 reflect activity by state departments, county health systems, and municipal agencies in Arizona, California, Florida, and Washington; issuers include the Washington State Department of Transportation (occupational medical surveillance), Collier County Board of County Commissioners (pharmacy benefit management), the City of Phoenix Retirement Office (disability medical evaluations), the City of Long Beach (surgical benefit carve-out), the County of Santa Clara Health System (temporary health professional staffing), and Harris County Juvenile Probation Department (emergency and specialty medical services for detained youth). Given the absence of procurement activity aligned with the code's actual scope—bypass procedures with autologous tissue substitutes delivered via percutaneous endoscopic approach—this code does not present a relevant business development opportunity in state and local government contracting at this time.